Author:
Nobrega de Almeida João,Assy João Guilherme Pontes Lima,Levin Anna S.,Del Negro Gilda M.B.,Giudice Mauro C.,Tringoni Marcela Pullice,Thomaz Danilo Yamamoto,Motta Adriana Lopes,Abdala Edson,Pierroti Ligia Camara,Strabelli Tania,Munhoz Ana Lucia,Rossi Flávia,Benard Gil
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference10 articles.
1. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.;Cendejas-Bueno;J Clin Microbiol,2012
2. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains.;Fujita;J Clin Microbiol,2001
3. Clinical Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27–A3, 3rd ed. Wayne, PA: National Committee for Clinical Laboratory Standards, The Institute; 2008.
4. Results from the ARTEMIS Dros Inf Serv.K Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.;Pfaller;J Clin Microbiol,2009
5. Candida auris-associated candidemia, South Africa.;Magobo;Emerg Infect Dis,2014
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献